Ventas, Inc.
Ventas Reports First Quarter Normalized Ffo of $92.4 Million and Fad of $87.8 Million
Published in Law and Health Weekly, May 24th, 2008
Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") said that first quarter 2008 normalized Funds from Operations ("FFO") increased 28 percent to $92.4 million from $72.1 million in the first quarter of 2007. Normalized FFO per diluted common share was $0.68 in the first quarter of both 2008 and 2007. Per share results were affected by an increase in the Company's weighted average diluted common shares outstanding to 136.7 million in the first quarter of 2008 from 106.8 million in the comparable 2007 period.
FFO per diluted common share, as defined by the National Association of Real Estate Investment Trusts ("NAREIT"), in the first quarter of 2008 increased to $0.75...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- AARP
AARP Welcomes Class of 2014 to its Board of Directors - AARP
Bill Novelli to Remain CEO of AARP - AARP
Third National GrandRally Brings Hundreds of Grandparents Raising Grandchildren to Washington - Affinity Technology Group, Inc.
Affinity Technology Group, Inc.: Court of Appeals Publishes Opinion in Patent Cases - Alzheimer Disease
Studies from University of Washington in the area of Alzheimer disease described - American Association of People With Disabilities
AAPD Urges U.S. Senate to Consider 21st Century Communications and Video Accessibility Legislation for People with Disabilities - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
